Drug Type Synthetic peptide |
Synonyms |
Target |
Action agonists |
Mechanism CNTFR agonists(Ciliary neurotrophic factor receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic Neuropathies | Phase 2 | European Union | - | |
| Diabetic Neuropathies | Phase 2 | United States | - |






